Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma (Q38994037)
Jump to navigation
Jump to search
scientific article published on 16 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma |
scientific article published on 16 May 2014 |
Statements
1 reference
Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma (English)
1 reference
1 reference
1 reference
1 reference
Australian Pancreatic Cancer Genome Initiative
1 reference
Wei Shi
1 reference
Murugan Kalimutho
1 reference
Mariska Miranda
1 reference
Adnan M Nagrial
1 reference
Angela Chou
1 reference
Kum Kum Khanna
1 reference
16 May 2014
1 reference
1 reference
Identifiers
1 reference